PMC:7600245 / 60603-60884 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T275","span":{"begin":78,"end":86},"obj":"Disease"},{"id":"T276","span":{"begin":123,"end":131},"obj":"Disease"},{"id":"T277","span":{"begin":209,"end":217},"obj":"Disease"},{"id":"T278","span":{"begin":238,"end":258},"obj":"Disease"}],"attributes":[{"id":"A275","pred":"mondo_id","subj":"T275","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A276","pred":"mondo_id","subj":"T276","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A277","pred":"mondo_id","subj":"T277","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A278","pred":"mondo_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/MONDO_0004768"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T625","span":{"begin":34,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T626","span":{"begin":45,"end":51},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24343","span":{"begin":22,"end":35},"obj":"Chemical"},{"id":"T39022","span":{"begin":191,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A75608","pred":"chebi_id","subj":"T24343","obj":"http://purl.obolibrary.org/obo/CHEBI_4031"},{"id":"A60789","pred":"chebi_id","subj":"T39022","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T70","span":{"begin":238,"end":258},"obj":"Phenotype"}],"attributes":[{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0001096"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T460","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1873","span":{"begin":55,"end":63},"obj":"Species"},{"id":"1874","span":{"begin":132,"end":140},"obj":"Species"},{"id":"1875","span":{"begin":218,"end":226},"obj":"Species"},{"id":"1883","span":{"begin":22,"end":35},"obj":"Chemical"},{"id":"1885","span":{"begin":78,"end":86},"obj":"Disease"},{"id":"1886","span":{"begin":123,"end":131},"obj":"Disease"},{"id":"1887","span":{"begin":209,"end":217},"obj":"Disease"},{"id":"1888","span":{"begin":232,"end":258},"obj":"Disease"}],"attributes":[{"id":"A1873","pred":"tao:has_database_id","subj":"1873","obj":"Tax:9606"},{"id":"A1874","pred":"tao:has_database_id","subj":"1874","obj":"Tax:9606"},{"id":"A1875","pred":"tao:has_database_id","subj":"1875","obj":"Tax:9606"},{"id":"A1883","pred":"tao:has_database_id","subj":"1883","obj":"MESH:D016572"},{"id":"A1885","pred":"tao:has_database_id","subj":"1885","obj":"MESH:C000657245"},{"id":"A1886","pred":"tao:has_database_id","subj":"1886","obj":"MESH:C000657245"},{"id":"A1887","pred":"tao:has_database_id","subj":"1887","obj":"MESH:C000657245"},{"id":"A1888","pred":"tao:has_database_id","subj":"1888","obj":"MESH:D007637"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Currently, the use of cyclosporin A is being tested in patients with moderate COVID-19 (NCT04412785; n = 20), hospitalized COVID-19 patients (NCT04392531; n = 120), and combined with topical corticosteroid in COVID-19 patients with acute keratoconjunctivitis (NCT04451239; n = 12)."}